140 filings
Page 7 of 7
6-K
gbp53s22
12 Feb 21
Interim condensed consolidated financial statements of
10:54am
6-K
6ya33q
30 Dec 20
Current report (foreign)
9:10pm
6-K
d43iiufd3x f9fy
9 Dec 20
Medicenna Announces Oral Presentation at the 2nd Annual Glioblastoma Drug Development Summit
9:04am
6-K
g942zdu yme
2 Dec 20
Medicenna Hosting Key Opinion Leader Call on MDNA55 for the Treatment of Recurrent Glioblastoma Multiforme
8:44am
6-K
rwjdx8 kyhz
23 Nov 20
Medicenna to Participate in Upcoming December Investor Conferences
7:35am
6-K
ygmreqsw1k2shbv6 xq
18 Nov 20
Medicenna Announces Upcoming Oral Presentations at the 2020 Society for Neuro-Oncology Annual Meeting
7:21am
6-K
w0g k8tewlwzac897l
13 Nov 20
Interim condensed consolidated financial statements of
1:51pm
6-K
xui76gs6r ui94zt
2 Nov 20
Medicenna to Present at Upcoming Scientific and Investor Events in November
7:51am
6-K
wgo07xjetigrk3a9v6lg
26 Oct 20
Medicenna Presents Late Breaking Abstract Updating Results from Phase 2b Recurrent GBM Trial at the 36th EORTC-NCI-AACR Meeting
8:39am
6-K
rz73y9 ve4s3xaejfm
26 Oct 20
Medicenna Presents Promising Preclinical Data on IL-2 and IL-13 Superkines at the EORTC-NCI-AACR Annual Meeting
8:34am
6-K
dn56t2c0grn679d8
19 Oct 20
Medicenna Announces Upcoming Presentations at the EORTC-NCI-AACR Annual Meeting
8:00am
6-K
spt5mj wn3l1r0ee
16 Oct 20
Current report (foreign)
12:00am
6-K
5lwwatxf1qveq4dclzu
1 Oct 20
Dr. Jack Geltosky Elected to Medicenna Board of Directors
12:00am
6-K
qb3miozcg8kpbxnq8
11 Sep 20
Current report (foreign)
11:06am
6-K
bkywqu6b4an9s6
9 Sep 20
Medicenna to Present at Upcoming Investor Conferences in September
8:29am
6-K
0ayjhp4
4 Sep 20
Current report (foreign)
2:50pm
6-K
tt1iwwu3cmz5ca4 6tl7
27 Aug 20
Form 51-102F3 Material Change Report
3:09pm
6-K
tuz xvlwg8zmnc
24 Aug 20
Notice of Change of Auditor
4:54pm
6-K
rja3 cca9dt
21 Aug 20
Current report (foreign)
10:30am
6-K
c4n2 in79jwpp1l
5 Aug 20
Condensed Consolidated Interim Statements of Financial Position
12:29pm